Weight gain combined with late first pregnancy or nulliparity is associated with an increased risk for breast cancer.

Simultaneous liver transplant and sleeve gastrectomy yield durable weight loss, resolution of diabetes and hypertension, and a reduction in allograft steatosis development.

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

Individuals with type 1 (T1D) and type 2 diabetes have a higher risk for ischemic stroke, but those with T1D also have a higher risk for hemorrhagic stroke.

Thyroid cancer-associated syndromes, including multiple endocrine neoplasia type 2, were significantly more prevalent than current estimates.

Adolescent hyperglycemia and worsening insulin resistance are associated with an increased risk for worsening structural and functional cardiac damage.

GLP-1 RAs were associated with significant reductions in body weight, BMI, and waist circumference among pediatric patients with obesity.